Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Alector, Inc.

Get SEC filing alerts via email and in your feed for Alector, Inc.

ALEC

Alector, Inc.

About Alector, Inc.

Alector, Inc. is a clinical-stage biotechnology company focused on developing genetically validated therapies for neurodegenerative diseases. Its core business involves creating monoclonal antibodies and biologics that elevate progranulin levels and target toxic proteins to restore brain cell function. Leveraging proprietary blood-brain barrier technology, Alector aims to enhance therapeutic delivery for conditions like frontotemporal dementia, Alzheimer’s, and Parkinson’s diseases, serving patients with high unmet medical needs.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Alector, Inc.

1
1
Alector, Inc. Alector Reports $22.9 Million Net Loss in Q1 2026, Improved from $40.5 Million Loss in Q1 2025

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Alector, Inc. Alector Reports $142.9 Million Net Loss for 2025, Collaboration Revenue Drops to $21 Million

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Alector, Inc. Alector Reports Q3 2025 Financial Results with Net Loss of $34.7 Million

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Alector, Inc. Alector Reports Q2 2025 Financial Results, Collaboration Revenue Declines to $7.9 Million

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Alector, Inc. Alector Reports $40.5 Million Net Loss in Q1 2025, Collaboration Revenue Declines

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Alector, Inc. Alector, Inc. Reports Financial Results for Q3 2024, Completes Public Offering and Implements Workforce Reduction

Via official filing (AI summary) | over 1 year ago | 0 comments